Joyce Cheung-Flynn
Last active: 5/22/2018

Joyce Cheung-Flynn, PhD

Official Affiliation: Surgery

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Vascular surgical stretch injury leads to activation of P2X7 receptors and impaired endothelial function. Komalavilas P, Luo W, Guth CM, Jolayemi O, Bartelson RI, Cheung-Flynn J, Brophy CM (2017) PLoS One 12(11): e0188069
    › Primary publication · 29136654 (PubMed) · PMC5685620 (PubMed Central)
  2. Limiting Injury During Saphenous Vein Graft Preparation For Coronary Arterial Bypass Prevents Metabolic Decompensation. Cheung-Flynn J, Song J, Voskresensky I, Wise ES, Liu Y, Xiong Y, Eagle SS, Brophy CM, Flynn CR (2017) Sci Rep 7(1): 14179
    › Primary publication · 29079734 (PubMed) · PMC5660200 (PubMed Central)
  3. Heparin-functionalized polymer graft surface eluting MK2 inhibitory peptide to improve hemocompatibility and anti-neointimal activity. Lee Y, Le Thi P, Seon GM, Ryu SB, Brophy CM, Kim Y, Park JC, Park KD, Cheung-Flynn J, Sung HJ (2017) J Control Release : 321-330
    › Primary publication · 28987880 (PubMed) · PMC5723561 (PubMed Central)
  4. P2X7R antagonism after subfailure overstretch injury of blood vessels reverses vasomotor dysfunction and prevents apoptosis. Luo W, Feldman D, McCallister R, Brophy C, Cheung-Flynn J (2017) Purinergic Signal 13(4): 579-590
    › Primary publication · 28905300 (PubMed) · PMC5714848 (PubMed Central)
  5. Unregulated saphenous vein graft distension decreases tissue viscoelasticity. Wise ES, Hocking KM, Evans BC, Duvall CL, Cheung-Flynn J, Brophy CM (2017) Perfusion 32(6): 489-494
    › Primary publication · 28820033 (PubMed) · PMC5967241 (PubMed Central)
  6. Adenosine triphosphate as a molecular mediator of the vascular response to injury. Guth CM, Luo W, Jolayemi O, Chadalavada KS, Komalavilas P, Cheung-Flynn J, Brophy CM (2017) J Surg Res : 80-86
    › Primary publication · 28807217 (PubMed) · PMC5962343 (PubMed Central)
  7. Calcification of Human Saphenous Vein Associated with Endothelial Dysfunction: A Pilot Histopathophysiological and Demographical Study. Pedigo SL, Guth CM, Hocking KM, Banathy A, Li FD, Cheung-Flynn J, Brophy CM, Guzman RJ, Komalavilas P (2017) Front Surg : 6
    › Primary publication · 28232909 (PubMed) · PMC5298955 (PubMed Central)
  8. Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury. Hocking KM, Luo W, Li FD, Komalavilas P, Brophy C, Cheung-Flynn J (2016) J Vasc Surg 64(1): 210-8
    › Primary publication · 25704409 (PubMed) · PMC4544660 (PubMed Central)
  9. Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function. Voskresensky IV, Wise ES, Hocking KM, Li FD, Osgood MJ, Komalavilas P, Brophy C, Cheung-Flynn J (2014) JAMA Surg 149(11): 1176-81
    › Primary publication · 25251505 (PubMed) · PMC4237645 (PubMed Central)
  10. Pressure control during preparation of saphenous veins. Li FD, Eagle S, Brophy C, Hocking KM, Osgood M, Komalavilas P, Cheung-Flynn J (2014) JAMA Surg 149(7): 655-62
    › Primary publication · 24759942 (PubMed) · PMC4102634 (PubMed Central)
  11. Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure? Osgood MJ, Harrison DG, Sexton KW, Hocking KM, Voskresensky IV, Komalavilas P, Cheung-Flynn J, Guzman RJ, Brophy CM (2012) Ann Vasc Surg 26(8): 1130-44
    › Primary publication · 22445245 (PubMed) · PMC4189806 (PubMed Central)
  12. Surgical skin markers impair human saphenous vein graft smooth muscle and endothelial function. Eagle S, Brophy CM, Komalavilas P, Hocking K, Putumbaka G, Osgood M, Sexton K, Leacche M, Cheung-Flynn J (2011) Am Surg 77(7): 922-8
    › Primary publication · 21944360 (PubMed) · PMC3957273 (PubMed Central)
  13. Functional specificity of co-chaperone interactions with Hsp90 client proteins. Riggs DL, Cox MB, Cheung-Flynn J, Prapapanich V, Carrigan PE, Smith DF (2004) Crit Rev Biochem Mol Biol 39(5-6): 279-95
    › Primary publication · 15763706 (PubMed)

Featured Affiliation

No featured affiliations

    View all affiliations

    Contact Information

    1161 21st Ave S
    T2105 MCN
    Nashville, TN 37232
    615-322-1344 (p)
    615-936-5988 (f)
    Email

    Keywords & MeSH Terms

    MeSH terms are retrieved from PubMed records. Learn more.

    Key: MeSH Term Keyword

    Apoptosis Calcium Signaling Cell Adhesion Molecules Corticotropin-Releasing Hormone Dermis Disease Models, Animal Escherichia coli Proteins Gene Expression Regulation Genetic Vectors Humans Immunoenzyme Techniques immunophilins intimal hyperplasia Mechanotransduction, Cellular Metabolomics Mitogen-Activated Protein Kinase 3 Neointima Phospholipids Point Mutation Primates Promoter Regions, Genetic Protein-Serine-Threonine Kinases Protein Structure, Tertiary purinergic receptors Rats Reactive Oxygen Species Repetitive Sequences, Nucleic Acid Skin Substrate Specificity Sucrose Transcription Factors Up-Regulation Vasoconstrictor Agents vasuclar biology vein graft preservation